Chimeric T-cell receptors: Highly specific tools to target cytotoxic T-lymphocytes to tumour cells

Cancer Treatment Reviews

Volumn 23, Issue 2, 1997, Pages 97-112

  Abken, H ^a   Hombach, A ^a   Heuser, C ^a   Sircar, R ^a   Pohl, C ^a   Reinhold, U ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; CANCER CELL; CANCER IMMUNOTHERAPY; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0030840780     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90023-2     Document Type: Article

References (42)

1. Rosenberg, S.A. (1992) The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10: 180-199.
2. Jain, R.K. (1989) Delivery of novel therapeutic agents in tumours: physiological barriers and strategies. J. Natl. Cancer Inst. 81: 570-576.
3. Lanzavecchia, A. & Scheidegger, D. (1987). The use of hybrid hybridomas to target human cytotoxicT lymphocytes. Eur. J. Immunol. 17: 105-111.
4. Hunkapiller, T. & Hood, L.E. (1989). Diversity of the immunoglobullin gene superfamily. Adv. Immunol. 44: 1-62.
5. Hochman, J., Inbar, D. & Givol, D. (1973) An active antibody fragment (Fv) composed of the variable protions of heavy and light chains. Biochemistry 12: 1130-135.
6. Kuwana, Y., Asakura, Y., Utsuomiya, N. et al. (1987) Expression of chimeric recpeotr composed of immunoglobulin-dreived V regions and T-cell receptor-derived C regions. Biochem. Biophys. Res. Commun. 149: 960-968.
7. Becker, M.L.B, Near, R., Mudgett-Hunter, M. et al. (1989) Expression of a hybrid immunoglobulinT-cell receptor protein in transfenic mice. Cell 58: 911-921.
8. Goverman, J., Gomez, S.M., Segesman, K.D., Hunkapiller, T., Lang, W.E. & Hood, L. (1990) Chimeric immunoglobulin-T-cell receptor complex formation and activation. Cell: 60 929-939.
9. Eshhar, Z., Waks, T., Gross, G. & Schindler D.G. (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζsubunits of the immunoglobulin and T cell receptors. Proc. Natl. Acad. Sci. USA 90: 720-724.
10. Brocker, T., Peter, A., Traunecker, A. & Karjalainen, K. (1993) New simplified molecular design for functional T cell receptor. Eur. J. Immunol. 23: 1435-1439.
11. Eshhar, Z. & Gross, G. (1990) Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach. Brit. J. Cancer 62 (suppl. 10): 27-29.
12. Gross, G., Gorochov, G., Waks, T. & Eshhar, Z. (1989) Generation of effector T cells expressing chimeric T cell receptor with antibody type specificity. Transplant. Proc. 21: 127-130.
13. Gross, G., Waks, T. & Eshhar, Z. (1989) Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc. Natl. Acad. Sci. USA 86: 10024-10028.
14. Romeo, C. & Seed, B. (1991) Cellular immunity to HIV activated CD4 fused to T cell or Fc receptor polypeptides. Cell 64: 1037-1046.
15. Irving, B.A. & Weiss, A. (1991) The cytoplasmic domain of the T cell receptor z chain is sufficient to couple to receptor associated signal transduction pathways. Cell 64: 891-901.
16. Gorochov, G., Gross, G., Waks, T. & Eshhar, Z. (1990) Expression of chimeric Ab/TCR genes as functional receptor molecules in human and mouse T cells. In: Lotz, M.T. & Finn, O.J., eds, Cellular Immunity and the Immunopathology of Cancer. New York: Wely-Liss Inc., p. 45.
17. Huston, J.S., Levinson, D., Mudgget-Hunter, M. et al. (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad Sci. USA 85: 5879-5884.
18. Bird, R.E., Hardman, K.D., Jacobson, J.W. et al. (1988) Single-chain antigen binding proteins. Science 242: 423-426
19. Bird, R.E & Walker, B.W. (1991) Single chain antibody variable regions. Biotech. 9: 133-137
20. Givol, D. (1991) The minimal antigen binding fragment of antibody Fv fragment. Mol. Immunol. 28: 1379-1386.
21. Ravetch, J.V. & Kinet, J.-P. (1991) Fc receptors. Annu. Rev. Immunol. 9: 457-492.
22. Orloff, D., Ra, C., Frank, S.J., Klausner, R.D. & Kinet, J.-P. (1990) Family of disulphide-linked dimers containing the ζ and ε chains of the T-cell receptor and the γ chain of Fc receptors. Nature 347: 189-191.
23. Wirthmuller, U., Kurosaki, T., Murakami, M.S. & Ravetch, J.V. (1992) Signal transduction by FcγRIII (CD16) is mediated through the γ chain. J. Exp. Med. 175: 1381-1390.
24. Moritz, D. & Groner, B. (1995) A spacer region between the single chain antibody- and the CD3 ζ-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signalling activity. Gene Therapy 2: 539-546.
25. Roberts, M.R., Quin, L., Zhang, D. et al. (1994) Targeting of human immunodeficiency virus-infected cells by CDS+ T lymphocytes armed with universal T-cell receptors. Blood 84: 2878-2889.
26. Brocker, T. & Karjalainen, K. (1995) Signals through T cell receptor-ζ chain alone are insufficient to prime resting T lymphocytes. J. Exp. Med. 181: 1653-1659.
27. Bach, N.L., Waks, T., Schindler, D.G. & Eshhar, Z. (1994) Functional expression in mast cells of chimeric receptors with antibody specificity. Cell Biophys. 24, 25: 229-236.
28. Stancovski, S., Schidler, D.G., Waks, T., Yarden, Y, Sela, M. & Eshhar, Z. (1993) Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 151: 6577-6582.
29. Moritz, D., Wels, W., Mattern, J. & Groner, B. (1994) Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumour cells. Proc. Natl. Acad. Sci. USA 91: 4318-4322.
30. Hwu, P., Shafer, G.E., Trisman, J. et al. (1993) Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor g chain. J. Exp. Med. 178: 361-366.
31. Hwu, P., Yang, J, Eshhar, Z. & Rosenberg, S.A. (1994) The genetic modification of T cells for cancer therapy: preclinical and clinical studies. Cancer Gene Therapy 1: 136.
32. Hombach, A., Heuser, C., Sircar, R. et al. The anti-CD30/FcγRIII chimeric receptor mediates MHC- and CD3-ζ independent T cell activation aganist Hodgkin's lymphoma cells. (Submitted.)
33. + tumour cells. Gastroenterol. (in press).
34. Reinhold, U., Liu, LiDe, Lüdtke-Handjery, H.-C. et al. Specific targeting of melanoma cells by cytotoxic T cells that express a chimeric receptor composed of the HMW-MAA binding domain and the g-signal transduction chain of the Fc receptor. (Submitted.)
35. Ferrone, S. & Marincola, F.M. (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance, Immunol. Today 16: 487-494.
36. Gross, G., Levy, S., Levy, R., Waks, T. & Eshhar, Z. (1995) Chimeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy. Biochem. Soc. Transact. 23: 1079-1083.
37. + T lymphocytes. Gene Therapy 3: 695-705.
38. Lustgarten, J. & Eshhar, Z. (1995) Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes. Eur. J. Immunol. 25: 2985-2991.
39. Finer, M.H., Dull, T.J., Quin, Lu, Farson, D. & Roberts, M.R. (1994) kat a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83: 43-50.
40. Walker, R.E. (1995) A phase I/II pilot study of the safety of the adoptive transfer of syngeneic gene-modified cytotoxic T lymphocytes in HIV-infected identical twins. Human Gene Therapy 7: 367-400.
41. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90: 8392-8396.
42. Weijtens, M.E.M., Willemsen, R.A., Valerio, D., Stam, K. & Bolhuis, R.L.H. (1996) Single chain Ig/γ gene-redirected human T lymphocytes produce cytokines, specifically lyse tumour cells, and recycle lytic capacity. J. Immunol. 157: 836-843.